Neoadjuvant Window Studies of Metformin and Biomarker Development for Drugs Targeting Cancer Metabolism (Q38524569)

3 September 2017

1 reference

title

Neoadjuvant Window Studies of Metformin and Biomarker Development for Drugs Targeting Cancer Metabolism (English)

1 reference

3 September 2017

0 references

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26063894%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Fergus Gleeson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26063894%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

Simon R Lord

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26063894%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Neel Patel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26063894%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Dan Liu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26063894%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

John Fenwick

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26063894%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Francesca Buffa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26063894%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

language of work or name

1 reference

1 May 2015

1 reference

Journal of the National Cancer Institute Monographs

3 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26063894%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

volume

2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26063894%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

issue

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26063894%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

81-86

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26063894%20AND%20SRC:MED&resulttype=core&format=json

On the Origin of Cancer Cells

13 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV011

Metformin decreases glucose oxidation and increases the dependency of prostate cancer cells on reductive glutamine metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV011

Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV011

Fatty acid synthase and cancer: new application of an old pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV011

Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV011

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV011

Antidiabetic therapies affect risk of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV011

Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV011

Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV011

Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV011

Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV011

The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV011

In vitro metformin anti-neoplastic activity in epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV011

Metformin is a potent inhibitor of endometrial cancer cell proliferation--implications for a novel treatment strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV011

Dual antiglioma action of metformin: cell cycle arrest and mitochondria-dependent apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV011

Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV011

Insulin and insulin-like growth factor signalling in neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV011

Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV011

Assessing early therapeutic response to bevacizumab in primary breast cancer using magnetic resonance imaging and gene expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV011

Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV011

Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV011

Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV011

18F-FDG PET and PET/CT in the evaluation of cancer treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV011

Metformin--an adjunct antineoplastic therapy--divergently modulates tumor metabolism and proliferation, interfering with early response prediction by 18F-FDG PET imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV011

Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV011

Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV011

AMPK: a nutrient and energy sensor that maintains energy homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV011

Reductive carboxylation supports growth in tumour cells with defective mitochondria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV011

Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV011

Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV011

Regulation of dietary fatty acid entrapment in subcutaneous adipose tissue and skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV011

Extreme loss of immunoreactive p-Akt and p-Erk1/2 during routine fixation of primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV011